A widely used diabetes drug holds promise in the treatment of the third biggest cancer killer in the UK, new research ...

People at high risk of acute myeloid leukaemia (AML) can be identified years in advance, but there is currently no treatment ...

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

Metformin, which is mainly used to control diabetes, could help prevent an aggressive form of blood cancer, a new study ...

Tirzepatide and GLP-1 receptor agonists are replacing older treatments, marking a shift in how diabetes and weight loss are ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.

At the end of 2023, more than one-third of new prescriptions to treat Type 2 diabetes were GLP-1s, such as Mounjaro and Ozempic, among others, according to a study published April 15 in Annals of ...